BNP Paribas Financial Markets
CYCN

BNP Paribas Financial Markets’s Cyclerion Therapeutics CYCN Stock Holding History

BNP Paribas Financial Markets’s Portfolio CYCN Stock Details CYCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14 Sell
4
-1
-20% -$3 ﹤0.01% 5867
2026
Q1 		$8 Hold
5
– – ﹤0.01% 5770
2025
Q4 		$6 Hold
5
– – ﹤0.01% 5702
2025
Q3 		$12 Hold
5
– – ﹤0.01% 5516
2025
Q2 		$15 Hold
5
– – ﹤0.01% 5400
2025
Q1 		$12 Hold
5
– – ﹤0.01% 5333
2024
Q4 		$16 Buy
+5
New +$14 ﹤0.01% 5354
2023
Q2 		– Sell
-5
Closed -$39 – 3934
2023
Q1 		$39 Sell
5
-11
-69% -$139 ﹤0.01% 3801
2022
Q4 		$208 Hold
16
– – ﹤0.01% 3923
2022
Q3 		$273 Hold
16
– – ﹤0.01% 4584
2022
Q2 		$174 Buy
16
+2
+14% +$29 ﹤0.01% 4003
2022
Q1 		$319 Hold
14
– – ﹤0.01% 4056
2021
Q4 		$494 Hold
14
– – ﹤0.01% 4113
2021
Q3 		$881 Buy
14
+3
+27% +$196 ﹤0.01% 3883
2021
Q2 		$881 Sell
11
-396
-97% -$24.8K ﹤0.01% 3953
2021
Q1 		$22.7K Buy
407
+184
+83% +$13.8K ﹤0.01% 3737
2020
Q4 		$13.7K Sell
223
-38
-15% -$2.59K ﹤0.01% 3899
2020
Q3 		$31.8K Buy
261
+196
+302% +$22.4K ﹤0.01% 3665
2020
Q2 		$7.72K Sell
65
-307
-83% -$25.7K ﹤0.01% 3821
2020
Q1 		$19.7K Buy
372
+192
+107% +$13.7K ﹤0.01% 3915
2019
Q4 		$9.82K Buy
180
+36
+25% +$3.36K ﹤0.01% 4127
2019
Q3 		$34.8K Buy
144
+53
+58% +$11.4K ﹤0.01% 3679
2019
Q2 		$20.8K Buy
+91
New +$25.8K ﹤0.01% 3880

Other funds holding CYCN

KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

BNP Paribas Financial Markets's CYCN Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Cyclerion Therapeutics (CYCN) stake by 20% in Q2 2026, selling an estimated $3 and leaving 4 shares worth $14. The position accounts for ﹤0.01% of the portfolio, ranked #5867.

BNP Paribas Financial Markets first reported a position in CYCN in Q2 2019 and has held it in 23 quarters since. The position peaked at $34.8K in Q3 2019. 21 funds tracked by Wall St. Rank hold CYCN as of Q2 2026.

  • BNP Paribas Financial Markets held 4 shares of Cyclerion Therapeutics worth $14 as of Q2 2026.
  • BNP Paribas Financial Markets sold 1 Cyclerion Therapeutics share in Q2 2026, an estimated $3.
  • Cyclerion Therapeutics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5867 holding.
  • BNP Paribas Financial Markets first reported a position in Cyclerion Therapeutics in Q2 2019 and has held it in 23 quarters since.
  • BNP Paribas Financial Markets's Cyclerion Therapeutics position peaked at $34.8K in Q3 2019.
  • 21 funds tracked by Wall St. Rank held Cyclerion Therapeutics as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.